theravance inc (THRX:NASDAQ GS)
Michael W. Aguiar
Chief Executive Officer, President and Director, Theravance Inc.
|Age||Total Calculated Compensation||This person is connected to 5 board members in 1 different organizations across 1 different industries.|
See Board Relationships
As of Fiscal Year 2014
Mr. Michael W. Aguiar, also known as Mike, has been the Chief Executive Officer and President of Theravance Inc., since August 15, 2014. Mr. Aguiar served as the Chief Financial Officer of Theravance Inc since March 7, 2005 and served as its Principal Accounting Officer and Treasurer. He has also been Senior Vice President of Finance at Theravance Inc. since March 7, 2005 and served as Secretary. He served as Vice President of Finance at Gilead Sciences. In his two years ...
951 Gateway BoulevardPhone: 650-238-9600
South San Francisco, California 94080
Board Members Memberships*
Chief Executive Officer, President and Director
University of Michigan
University of California, Irvine
|Howard W. Robin||Chief Executive Officer, President and Director|
|Peter M. Hecht Ph.D.||Co-Founder, Chief Executive Officer and Director|
Ironwood Pharmaceuticals, Inc.
|Mark R. Baker J.D.||Chief Executive Officer, Director and Member of Science & Strategy Committee|
Progenics Pharmaceuticals, Inc.
|Peter S. Greenleaf||Chief Executive Officer, Director, Member of Commercialization Committee and Member of Science & Technology Committee|
Sucampo Pharmaceuticals, Inc.
|Richard Martin Steeves Ph.D.||Group Chief Executive Officer, Member of Senior Executive Board and Executive Director|
Synergy Health plc
|823.0K GBP||Compensation as of Fiscal Year 2013.|